Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 37 | ECE2015 | Next issue

17th European Congress of Endocrinology

Eposter Presentations

Obesity and cardiovascular endocrinology

Previous section
Diabetes (complications & therapy)
Table of contents
Next section
Pituitary: basic and neuroendocrinology

ea0037ep542 | Obesity and cardiovascular endocrinology

Subclinical hypothyroidism and features of metabolic syndrome in Saudi elderly women

ea0037ep543 | Obesity and cardiovascular endocrinology

Controlling the obesity epidemic: where does the pharmacist weigh in?

ea0037ep544 | Obesity and cardiovascular endocrinology

Effect of site of waist measurement on the prevalence of metabolic syndrome

ea0037ep545 | Obesity and cardiovascular endocrinology

Calculating serum LDL cholesterol (LDL-C): comparison of LDL-C measured by direct assay with various formulae by combination of ages, genders, and triglycerides

ea0037ep546 | Obesity and cardiovascular endocrinology

Glucose metabolism regulation in morbidly obese patients and in patients after biliopancreatic diversion

ea0037ep547 | Obesity and cardiovascular endocrinology

The relationship between the subclinical target organ damage and the levels of ischemia-modified albumin in hypertensive patients

ea0037ep548 | Obesity and cardiovascular endocrinology

The relationship between socioeconomic level, and the prevalence of masked hypertension and asymptomatic organ damage

ea0037ep549 | Obesity and cardiovascular endocrinology

Management of hypoglycaemia after gastric bypass: a difficult challenge

ea0037ep550 | Obesity and cardiovascular endocrinology

The impact of the socio-demographic and lifestyle factors on central obesity and overweight status using structural equation modelling: Tehran Lipid and Glucose Study

ea0037ep551 | Obesity and cardiovascular endocrinology

The influence of metabolic syndrome to cardiovascular events in a 10-year prospective study

ea0037ep552 | Obesity and cardiovascular endocrinology

Influence of normal food intake on the lipid profile of diabetic patients

ea0037ep553 | Obesity and cardiovascular endocrinology

The functional parameters of renin-angiotensin-aldosterone system in obese patients

ea0037ep554 | Obesity and cardiovascular endocrinology

Enzymes of the vitamin K cycle and progression of calcification in the vessel wall

ea0037ep555 | Obesity and cardiovascular endocrinology

Weight loss with bariatric surgery improves ischaemia modified albumin levels and oxidative status in morbidly obese patients

ea0037ep556 | Obesity and cardiovascular endocrinology

Metformin treatment of hypothalamic obesity: the lesson of two cases

ea0037ep557 | Obesity and cardiovascular endocrinology

Glycolysis in septic patients during early ICU hospitalisation shows differences vis-a-vis shock resolution

ea0037ep558 | Obesity and cardiovascular endocrinology

Renal hemodynamic status in patients with different classes of obesity

ea0037ep559 | Obesity and cardiovascular endocrinology

Influence of anthropometric parameters, leptin, adiponectin, and insulin resistance on blood pressure in obese women

ea0037ep560 | Obesity and cardiovascular endocrinology

Galectin-3 and fibulin-1 in systolic heart failure patients with and without diabetes: relation to glucose metabolism and left ventricular contractile reserve

ea0037ep561 | Obesity and cardiovascular endocrinology

The effect of the type of the bariatric surgery in the lipid profile: an age, sex, BMI, and excess weight loss matched study

ea0037ep562 | Obesity and cardiovascular endocrinology

Comparison of demographic and biochemical characteristics among younger and older patients with metabolic syndrome

ea0037ep563 | Obesity and cardiovascular endocrinology

The risk of future IRS among women with history of gestational diabetes

ea0037ep564 | Obesity and cardiovascular endocrinology

Haematopoietic system 3 years after gastric bypass

ea0037ep565 | Obesity and cardiovascular endocrinology

Patients with acute coronary syndrome have lower testosterone then healthy controls

ea0037ep566 | Obesity and cardiovascular endocrinology

HLA and metabolic parameters that define obesity in Amerindians for the first time

ea0037ep567 | Obesity and cardiovascular endocrinology

Does the presence of obesity and/or metabolic syndrome affect the course of acute pancreatitis?

ea0037ep568 | Obesity and cardiovascular endocrinology

Gender-related risk of cardiovascular diseases in patients with type 2 diabetes mellitus

ea0037ep569 | Obesity and cardiovascular endocrinology

Effect of obesity and diabetes mellitus type 2 on vascular stiffness

ea0037ep570 | Obesity and cardiovascular endocrinology

Metabolism of sphingolipids in experimental obesity and insulin resistance

ea0037ep571 | Obesity and cardiovascular endocrinology

Adiponectin response to vegetarian diet is gender-dependent and inversely related to uric acid

ea0037ep572 | Obesity and cardiovascular endocrinology

Fibrate therapy predispose to influenza vaccine-induced rabdomyolysis

ea0037ep573 | Obesity and cardiovascular endocrinology

Outcomes of gastric bypass for morbid obesity after 5-year follow-up

ea0037ep574 | Obesity and cardiovascular endocrinology

The prevalence of obesity and metabolic syndrome among inpatients at a Forensic Psychiatric Hospital in the Republic of Ireland

ea0037ep575 | Obesity and cardiovascular endocrinology

Can obese patients on antipsychotic medications achieve weight loss in an unmodified general population lifestyle-intervention weight management programme?

ea0037ep576 | Obesity and cardiovascular endocrinology

Factors affecting gender differences in the association between health-related quality of life and metabolic syndrome components: Tehran Lipid and Glucose Study (TLGS)

ea0037ep577 | Obesity and cardiovascular endocrinology

Secondary prevention after acute coronary syndrome in patients with type 2 diabetes: results from a routine clinical practice

ea0037ep578 | Obesity and cardiovascular endocrinology

A 5-year review of the metabolic changes after laparoscopic sleeve gastrectomy among obese Hong Kong Chinese in a regional hospital

ea0037ep579 | Obesity and cardiovascular endocrinology

Malignant tumours in patients with type 2 diabetes mellitus and obesity

ea0037ep580 | Obesity and cardiovascular endocrinology

Preoperative endocrinological evaluation of patients apply for bariatric surgery

ea0037ep581 | Obesity and cardiovascular endocrinology

Liver enzymes and triglycerides predict biomarkers of insulin sensitivity in obese, non-diabetic adult patients

ea0037ep582 | Obesity and cardiovascular endocrinology

Neutrophil to lymphocyte ratio as an inflammatory marker in obesity

ea0037ep583 | Obesity and cardiovascular endocrinology

A prospective prevalence study of functional adrenal insufficiency and its outcome in acute myocardial infarction in UKMMC

ea0037ep584 | Obesity and cardiovascular endocrinology

Adipocytokine responses to acute exercise in athletes with different body fat content and sedentary controls

ea0037ep585 | Obesity and cardiovascular endocrinology

Anti-obesity effect of Aster spathulifolius Maxim extract

ea0037ep586 | Obesity and cardiovascular endocrinology

The assessment of environmental and hereditary factors in obesity patients

ea0037ep587 | Obesity and cardiovascular endocrinology

Significance of cognitive-behavioural therapy in the treatment of obesity

ea0037ep588 | Obesity and cardiovascular endocrinology

Fine motor skill proficiency in obese children

ea0037ep589 | Obesity and cardiovascular endocrinology

High mean platelet volume in morbid obesity

ea0037ep590 | Obesity and cardiovascular endocrinology

Genetic variation in GLP1 receptor is associated with interindividual differences in weight lowering potential of liraglutide in obese women with PCOS

ea0037ep591 | Obesity and cardiovascular endocrinology

The efficacy of lifestyle modification in preventing type 2 diabetes mellitus in subjects with impaired glucose homeostasis

ea0037ep592 | Obesity and cardiovascular endocrinology

Relationship between thyroid hormone status and concomitant medication in hyperlipidaemic patients with statin induced adverse effects

ea0037ep593 | Obesity and cardiovascular endocrinology

Is there a relationship between parathyroid hormone and obesity-linked disorders

ea0037ep594 | Obesity and cardiovascular endocrinology

Cardiovascular disease in patients with primary hyperparathyroidism

ea0037ep595 | Obesity and cardiovascular endocrinology

N-terminal pro-brain natriuretic peptide – an early independent predictor of anthracycline-induced cardiomyopathy

ea0037ep596 | Obesity and cardiovascular endocrinology

Increased expression of ATP-binding cassette transporter A1 by cilostazol may be a possible mechanism for its protective effect against hepatic steatosis

ea0037ep597 | Obesity and cardiovascular endocrinology

Exploratory study a Brazilian population with multiple chronic conditions from the perspective of smoking

ea0037ep598 | Obesity and cardiovascular endocrinology

TNFα induces lipolysis by downregulating CIDEC via MEK/ERK-dependent PPARγ phosphorylation and nuclear exportation

ea0037ep599 | Obesity and cardiovascular endocrinology

Magnitude of overweight and obesity amongst school children in Delhi, India

ea0037ep600 | Obesity and cardiovascular endocrinology

Altered sensory motor integration of obese adults

ea0037ep601 | Obesity and cardiovascular endocrinology

The effectiveness of an integrated approach in the treatment of obesity

ea0037ep602 | Obesity and cardiovascular endocrinology

SHBG-C57BL/ksJ-db/db: a new mouse model to study the link between SHBG regulation and obesity development

ea0037ep603 | Obesity and cardiovascular endocrinology

Adiponectin deletion impairs insulin signalling in insulin-sensitive but not insulin-resistant 3T3-L1 adipocytes

ea0037ep604 | Obesity and cardiovascular endocrinology

Who is the Belarusian citizen seeking for losing weight?!

ea0037ep605 | Obesity and cardiovascular endocrinology

Long-term glucocorticoid concentrations as a risk factor for childhood obesity and adverse body fat distribution

ea0037ep606 | Obesity and cardiovascular endocrinology

From genome to gene: genes and genetic variations to be associated with metabolic syndrome

ea0037ep607 | Obesity and cardiovascular endocrinology

Audit of metabolic profiles in women with Turner syndrome

ea0037ep608 | Obesity and cardiovascular endocrinology

Metabolic syndrome and cardiovascular risk in frail elderly people

ea0037ep609 | Obesity and cardiovascular endocrinology

Investigation of the transient receptor potential channel gene expressions in metabolic syndrome

ea0037ep610 | Obesity and cardiovascular endocrinology

Linking temperature to metabolism: the role of brown adipose tissue in humans

ea0037ep611 | Obesity and cardiovascular endocrinology

C-reactive protein assay in obese paediatric patients: comparison of two laboratory methods

ea0037ep612 | Obesity and cardiovascular endocrinology

Does IGF influence the prognosis 10 months after myocardial infarction?

ea0037ep613 | Obesity and cardiovascular endocrinology

Association between the transient receptor potential channel gene polymorphisms and metabolic syndrome

ea0037ep614 | Obesity and cardiovascular endocrinology

Effects of omega-3 fatty acid on pre- and post-prandial triglyceride and metabolic parameters with standard meals in patients with hypertriglyceridemia: open, multicentre study

ea0037ep615 | Obesity and cardiovascular endocrinology

Neutrophil to lymphocyte ratio: relationship with anthropometric and metabolic parameters in morbidly obese patients

ea0037ep616 | Obesity and cardiovascular endocrinology

A low glycaemic index, low glycaemic load snack based on stevia and fortified with vitamin D, improves metabolic/hormonal profile, and compliance in normal subjects and prediabetics; results from a 4 months, controlled trial

ea0037ep617 | Obesity and cardiovascular endocrinology

Intima–media thickness measurement of the carotid artery in patients with primary hyperparathyroidism

ea0037ep618 | Obesity and cardiovascular endocrinology

Impact of laparoscopic gastric bypass and sleeve gastrectomy on anti-hyperglycaemic medication use in pre-existing type 2 diabetes mellitus

ea0037ep619 | Obesity and cardiovascular endocrinology

Steroid hormones related to 11β-hydroxysteroid dehydrogenase in obese adolescents and non-obese controls

ea0037ep620 | Obesity and cardiovascular endocrinology

Liraglutide improves surfactant protein-B production and reduces right ventricular hypertrophy in a rat model of intersitial pulmonary fibrosis

ea0037ep621 | Obesity and cardiovascular endocrinology

Metabolic syndrome and muscle mass

ea0037ep622 | Obesity and cardiovascular endocrinology

Increased FNDC5 (irisin) expression in subcutaneous adipose tissue in obese patients with type 2 diabetes 1 year after bariatric surgery

ea0037ep623 | Obesity and cardiovascular endocrinology

Relationship between TSH and cortisol levels in euthyroid obese subjects

ea0037ep624 | Obesity and cardiovascular endocrinology

Levels of advanced glycation end products (AGEs), AGE's receptor (sRAGE) and their relationship with cardiovascular risk factors in newly diagnosed type 2 diabetic patients

ea0037ep625 | Obesity and cardiovascular endocrinology

The body distribution of iodine-125 labeled irisin in 10-week-old rats: preliminary data

ea0037ep626 | Obesity and cardiovascular endocrinology

Obesity and breast cancer – does size matter?

ea0037ep627 | Obesity and cardiovascular endocrinology

Irisin/leptin ratio, a biological marker of lean/fat mass, may help to identify LMNA-mutated familial partial lipodystrophies

ea0037ep628 | Obesity and cardiovascular endocrinology

The relation between metabolic syndrome and cognitive decline in type 2 diabetes elderly Tunisian people

ea0037ep629 | Obesity and cardiovascular endocrinology

IGF-1 levels correlate with T3 status in chronic heart failure outpatients: preliminary data

ea0037ep630 | Obesity and cardiovascular endocrinology

Diet relationship with the metabolic syndrome's elements

ea0037ep631 | Obesity and cardiovascular endocrinology

A common variant (rs9939609) in the fat mass and obesity associated gene is not associated with obesity, but associated with metabolic syndrome in girls among adolescents

ea0037ep632 | Obesity and cardiovascular endocrinology

The relationship between haemoglobin and BMI in overweight and obese patients

ea0037ep633 | Obesity and cardiovascular endocrinology

Advanced glycation end products, their receptors RAGE and AGER-1 and their association with insulin resistance and inflammation in obese and non-obese young subjects

ea0037ep634 | Obesity and cardiovascular endocrinology

Bone and calcium markers in relation to cardiovascular risk in patients with osteoporosis

ea0037ep635 | Obesity and cardiovascular endocrinology

Therapeutic education contributes to minimise excess weight in Prader-Willi syndrome

ea0037ep636 | Obesity and cardiovascular endocrinology

The use of intermittent 7.5 mg tolvaptan on an out-patient basis for SIADH: a retrospective audit from a tertiary cancer hospital

ea0037ep637 | Obesity and cardiovascular endocrinology

Type 2 diabetes mellitus and obesity: the possibilities of antihypertensive therapy

ea0037ep638 | Obesity and cardiovascular endocrinology

Serum adipokine profile and adiponectin gene expression in neck adipose tissue in premenopausal and postmenopausal women

ea0037ep639 | Obesity and cardiovascular endocrinology

Impact of visceral adiposity on blood pressure in normotensive people: a study among health staff

ea0037ep640 | Obesity and cardiovascular endocrinology

Metabolic consequences of abdominal obesity: about 105 Algerian obese patients

ea0037ep641 | Obesity and cardiovascular endocrinology

Body composition in HIV-infected patients under combined antiretroviral therapy over 5 years

ea0037ep642 | Obesity and cardiovascular endocrinology

Patients' expectations and post-bariatric surgery satisfaction

ea0037ep643 | Obesity and cardiovascular endocrinology

Insulin resistance does not play a major role in lipid and apolipoprotein profile in obese women

ea0037ep644 | Obesity and cardiovascular endocrinology

VEGFA expression is regulated by 17β-oestradiol and its receptors (ESR1 and ESR2) on 3T3-L1 adipocytes

ea0037ep645 | Obesity and cardiovascular endocrinology

Time-of-day-dependent rhythms in the transcriptional responsiveness of the rat heart to triiodothyronine

ea0037ep646 | Obesity and cardiovascular endocrinology

Influences on post-bariatric surgery satisfaction

ea0037ep647 | Obesity and cardiovascular endocrinology

Effects of an 8-week supervised, structured lifestyle modification programme on anthropometric, metabolic, and cardiovascular risk factors in severely obese adults

ea0037ep648 | Obesity and cardiovascular endocrinology

Skin tags and metabolic phenotype in severely obese adults: the STAMP cohort study

ea0037ep649 | Obesity and cardiovascular endocrinology

Prevalence of metabolic syndrome among human immunodeficiency virus and hepatitis C subjects in Southern Brazil

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more